Literature DB >> 9800779

Magnesium sulphate in eclampsia. Eclampsia Trial Collaborative Group.

L Duley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9800779     DOI： 10.1016/s0140-6736(05)79550-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Headache and seizure on postpartum day 5: late postpartum eclampsia.

Authors:  Val E Ginzburg; Bryan Wolff
Journal:  CMAJ       Date:  2009-02-17       Impact factor: 8.262

Review 2.  Magnesium sulphate versus diazepam for eclampsia.

Authors:  Lelia Duley; David J Henderson-Smart; Godfrey Ja Walker; Doris Chou
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

3.  Magnesium sulfate is not used for pre-eclampsia and eclampsia in Mexico and Thailand as much as it should be.

Authors:  Pisake Lumbiganon; A Metin Gülmezoglu; Gilda Piaggio; Ana Langer; Jeremy Grimshaw
Journal:  Bull World Health Organ       Date:  2007-10       Impact factor: 9.408

4.  Hypertensive Encephalopathy.

Authors:  Olajide Williams; John C.M. Brust
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-06

5.  Super-selective intra-arterial magnesium sulfate in combination with nicardipine for the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage.

Authors:  Qaisar A Shah; Muhammad Zeeshan Memon; M Fareed K Suri; Gustavo J Rodriguez; Osman S Kozak; Robert A Taylor; Ramachandra P Tummala; Gabriela Vazquez; Alexandros L Georgiadis; Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2009-04-16       Impact factor: 3.210

Review 6.  Clinical review: Special populations--critical illness and pregnancy.

Authors:  Patrick J Neligan; John G Laffey
Journal:  Crit Care       Date:  2011-08-12       Impact factor: 9.097

Review 7.  The Importance of Magnesium in Clinical Healthcare.

Authors:  Gerry K Schwalfenberg; Stephen J Genuis
Journal:  Scientifica (Cairo)       Date:  2017-09-28

8.  Availability and use of magnesium sulphate at health care facilities in two selected districts of North Karnataka, India.

Authors:  Geetanjali Katageri; Umesh Charantimath; Anjali Joshi; Marianne Vidler; Umesh Ramadurg; Sumedha Sharma; Sheshidhar Bannale; Beth A Payne; Sangamesh Rakaraddi; Chandrashekhar Karadiguddi; Geetanjali Mungarwadi; Avinash Kavi; Diane Sawchuck; Richard Derman; Shivaprasad Goudar; Ashalata Mallapur; Mrutyunjaya Bellad; Laura A Magee; Rahat Qureshi; Peter von Dadelszen
Journal:  Reprod Health       Date:  2018-06-22       Impact factor: 3.223
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.